COMPARATIVE EFFECTIVENESS OF PERINDOPRIL AND LOSARTAN IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY

QR Code

COMPARATIVE EFFECTIVENESS OF PERINDOPRIL AND LOSARTAN IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY

Aim. To assess the antihypertensive effectiveness of perindopril А and losartan and their influence on the main cardiovascular risk factors among patients with arterial hypertension and obesity. Material and methods. This single-blind, randomised, comparative parallel study included patients either...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. V. Nedogoda, A. A. Ledyaeva, E. V. Chumachek, V. V. Tsoma, G. G. Mazina, A. S. Salasyuk, I. N. Barykina
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2012-02-01
Series:	Российский кардиологический журнал
Subjects:	hyperuricemia gout arterial hypertension pulse wave velocity losartan
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1195
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Losartan therapy and hyperuricemia correction in patients with metabolic syndrome and arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2011-12-01)

Losartan therapy in gout patients
by: A. I. Ilyina, et al.
Published: (2008-04-01)

Comparative effectiveness of original and generic losartan in patients with arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2007-12-01)

Angiotensin II receptor antagonist and ACE inhibitor effectiveness in cognitive function correction among elderly patients with arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2007-06-01)

Comparative effectiveness of perindopril and enalapril in patients with arterial hypertension and obesity
by: S. V. Nedogoda, et al.
Published: (1970-01-01)

ADDITIONAL ANGIOPROTECTION AND METAbOLIC DISORDERS CORRECTION IN TREATMENT OF ARTERIAL HYPERTENSION PATIENTS REACHED TARGET bLOOD PRESSURE LEVELS, WITH FIxED COMbINATION OF PERINDOPRIL AND INDAPAMIDE
by: S. V. Nedogod, et al.
Published: (2018-05-01)

Effectiveness of in insulin resistance correction and the adipokines level reduction in patients with arterial hypertension in comparison with other ARBs
by: S. V. Nedogoda, et al.
Published: (2019-02-01)

Azilsartan medoxomil for improving insulin resistance and adipokine levels in hypertension in comparison with angiotensin-converting enzyme inhibitors
by: S. V. Nedogoda, et al.
Published: (2020-08-01)

Acarbose effects on vascular stiffness in patients with arterial hypertension and metabolic syndrome
by: S. V. Nedogoda, et al.
Published: (2006-04-01)

Perspectives of decreasing individual cardiovascular risk in high- and very high risk patients with arterial hypertension, treated with rilmenidine
by: S. V. Nedogoda, et al.
Published: (2005-06-01)

Losartan in postmenopausal women with essential arterial hypertension
by: O. N. Tkacheva, et al.
Published: (2010-12-01)

Optimal Organ Protection and Blood Pressure Control with the Single Pill Combination Lisinopril, Amlodipine and Indapamide in Arterial Hypertension
by: S. V. Nedogoda, et al.
Published: (2020-12-01)

The effect of various classes of glucose-lowering medications on the blood vessel elasticity in patients with type 2 diabetes
by: S. V. Nedogoda, et al.
Published: (2020-05-01)

Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part I: the current state of the problem
by: M. S. Eliseev, et al.
Published: (2022-10-01)

Comparison of colorimetric and electrochemical (Easy Touch GCU Meter) methods for determination of blood uric acid in clinical practice in patients with gout and hyperuricemia (data from a pilot study)
by: M. S. Eliseev, et al.
Published: (2023-10-01)

Asymptomatic hyperuricemia and gout: Are there any differences (data from a pilot case-control study)
by: M. S. Eliseev, et al.
Published: (2025-07-01)

Losartan effectiveness in arterial hypertension patients (ELLA study)
by: I. E. Chazova, et al.
Published: (2007-04-01)

OPTIMAL ORGANOPROTECTION, CONTROL OF bLOOD PRESSURE AND METAbOLIC DISORDER WITH THE FIxED COMbINATION OF LISINOPRIL, AMLODIPINE AND ROSUVASTATIN IN SYSTEMIC HYPERTENSION
by: S. V. Nedogoda, et al.
Published: (2018-05-01)

Current ideas on the pathogenesis of uric acid nephrolithiasis and its correction methods in gouty patients
by: V G Barskova, et al.
Published: (2011-12-01)

AORTIC STIFFNESS ASSESSMENT IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY
by: E. Yu. Shupenina, et al.
Published: (2013-06-01)

The diagnosis, treatment and prevention of gout: The 2014 international clinical guidelines
by: N. T. Vatutin, et al.
Published: (2015-09-01)

NEW INTERNATIONAL RECOMMENDATIONS FOR THE DIAGNOSIS AND TREATMENT OF GOUT
by: M. S. Eliseev
Published: (2014-06-01)

GOUT OUTCOMES. A REVIEW OF LITERATURE. PART 1. GOUT: EPIDEMIOLOGY, RISK FACTORS, COURSE OF THE DISEASE WITH THE DEVELOPMENT OF CHRONIC TOPHUS FORM
by: Igor Sergeyevich Denisov, et al.
Published: (2013-12-01)

GOUT OUTCOMES. LITERATURE REVIEW. PART II. COMORBID DISEASES, RISK OF DEVELOPING CARDIOVASCULAR CATASTROPHES AND DEATH IN GOUT PATIENTS
by: Igor Sergeevich Denisov, et al.
Published: (2014-02-01)

COMPARATIVE EVALUATION OF THE ANTIHYPERTENSIVE EFFECT OF PERINDOPRIL AND LOSARTAN POTASSIUM IN PATIENTS WITH ARTERIAL HYPERTENSION AND STENOTIC CORONARY ATHEROSCLEROSIS BEFORE REVASCULARIZATION: AN OPEN RANDOMIZED COMPARATIVE STUDY
by: O. A. Osipova, et al.
Published: (2016-01-01)

Optimization of blood pressure control, organ protection and metabolic disorders using a fixed-dose combination of lisinopril+amlodipine+rosuvastatin in hypertensive patients after COVID-19
by: S. V. Nedogoda, et al.
Published: (2022-01-01)

СARDIOPROTECTION IN PATIENTS WITH HYPERTENSION – THE ROLE OF LOSARTAN
by: I. I. Chukaeva, et al.
Published: (2015-09-01)

Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2008-10-01)

Arterial stiffness: basic determinants, methods of assessment, and the connection with obesity in children (literature review)
by: L. V. Danilyuk, et al.
Published: (2017-09-01)

Clinical experience with Uralyt-U used in patients with gout and nephrolithiasis
by: M S Eliseyev, et al.
Published: (2012-03-01)

Two cases of acute urate nephropathy in women with asymptomatic hyperuricemia
by: L. N. Yeliseyeva, et al.
Published: (2021-03-01)

MORPHOLOGICAL AND FUNCTIONAL CHARACTERISTICS OF THE MAIN ARTERIES AND PULSE WAVE VELOCITY IN OLDER AGE INDIVIDUALS WITH ARTERIAL HYPERTENSION
by: G. G. Efremushkin, et al.
Published: (2014-08-01)

Mechanisms of cartilage damage in gout and hyperuricemia
by: E. V. Panina
Published: (2024-04-01)

EFFICACY OF A FIXED COMBINATION OF LOSARTAN AND AMLODIPINE IN PATIENTS WITH ARTERIAL HYPERTENSION: SEASONAL FEATURES
by: M. D. Smirnova, et al.
Published: (2017-06-01)

Hyperuricemia and hypertension in working-age people: results of a population study
by: S. A. Shalnova, et al.
Published: (2023-12-01)

Pulse wave velocity in arterial hypertension patients
by: O. A. Nazarova, et al.
Published: (2007-04-01)

USE OF HERBAL REMEDY URISAN AS BASIC THERAPY FOR GOUT
by: Tamila Nilovna Khalfina, et al.
Published: (2010-06-01)

Effectiveness of an angiotensin II receptor blocker losartan as monoand combined therapy in hypertensive patients with various levels of renin-angiotensin-aldosterone system activity
by: Sh. V. Akhadov, et al.
Published: (2011-02-01)

Risk factors for type 2 diabetes mellitus in patients with gout: results from a prospective study
by: O. V. Zhelyabina, et al.
Published: (2022-02-01)

THE ALTERNATIVE TOOLS FOR PREDICTION OF CARDIOVASCULAR RISK IN OBESITY: FOCUS ON ARTERIAL STIFFNESS
by: M. A. Druzhilov, et al.
Published: (2016-12-01)